openPR Logo
Press release

Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market Development Factors, Investment Analysis By Top Players like GlaxoSmithKline plc, Helsinn Holding S.A., Heron Therapeutics, Inc. and Merck & Co., Inc.

02-05-2019 12:59 PM CET | Health & Medicine

Press release from: Allied Market Research

Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market

Increase in adoption of chemotherapeutic drugs is directly linked to the growth of the CINV drugs market. It is estimated that in 2016, approximately 1.6 million new cases of cancer will be diagnosed with breast, lung, and bronchus cancer. It is observed that approximately 35% of patients experienced nausea within 24 hours of chemotherapy, while 54% suffered from nausea and 34% experienced vomiting after 24 hours.

Growth in number of patients undergoing chemotherapy drugs treatment and introduction of new drug delivery methods to improve patient compliance are the major factors that significantly impact the growth of the CINV market. At present, pharmaceutical companies are increasingly investing in the R&D of CINV drugs to offer better chemotherapy drugs and increase their market share.Chemotherapy-induced Nausea and Vomiting (CINV) Market report, published by Allied Market Research, forecasts that the global market is expected to garner $2,659 million by 2022, growing at a CAGR of 7.1% during 2016-2022.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-sample/1846

Chemotherapy-induced nausea and vomiting (CINV) drugs market experiences growth due to increase in number of patients undergoing chemotherapy and increased uptake of low toxicity targeted treatments. Some of the key drugs in the market are Akynzeo, Emend, Aloxi, Zofran, Kytril and SUSTOL and Rolapitant. At present, pharmaceutical companies have prioritized investment in R&D of CINV drugs for driving their profit margins and sustain the use of chemotherapeutic drugs.

Granisetron transdermal patch with the trade name Sancuso was approved by the US FDA. It is manufactured by 3M Drug Delivery Systems. Granisetron is a selective inhibitor of type 3 serotonergic (5-HT3) receptors. It has little or no affinity for other serotonin receptors, including 5-HT 1, 5-HT 1A, 5-HT, or 5-HT 2. The cancer population living in the developing economies of LAMEA and Asia-Pacific are adopting novel CINV drug delivery methods such as combination therapies and transdermal patches to minimize the side effects of chemotherapeutic drugs. CINV market in North America generates the largest share of global CINV drugs market, followed by Europe and Asia-Pacific. The demand for CINV drugs market in Asia-Pacific market is expected to post the fastest growth for CINV drugs market.

Top Key Players :

• GlaxoSmithKline plc
• Helsinn Holding S.A.
• Heron Therapeutics Inc.
• Merck & Co. Inc.
• Tesaro Inc

The North American market has witnessed a significant growth in the recent years. Presently, it is the largest regional market for CINV drugs and an its market share is anticipated by 2022. Asia-Pacific is the fastest growing market due to increase in number of cancer population, high incidences of gastroenteritis and other diseases that lead to nausea and vomiting. This region boosts up the demand for antiemetic drug due to growth in demand for CINV drugs and is expected to fuel the market growth in this region.
Partnership and collaboration is the key strategy adopted by companies to strengthen their position in the market.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/1846

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chemotherapy-Induced Nausea And Vomiting (CINV) Market Development Factors, Investment Analysis By Top Players like GlaxoSmithKline plc, Helsinn Holding S.A., Heron Therapeutics, Inc. and Merck & Co., Inc. here

News-ID: 1561062 • Views:

More Releases from Allied Market Research

Driving Innovation : Automotive Hypervisor Market to Hit $2.04 Billion by 2030, Fueled by a 31.9% CAGR
Driving Innovation : Automotive Hypervisor Market to Hit $2.04 Billion by 2030, …
According to a recent report published by Allied Market Research, titled, "Automotive Hypervisor Market by Vehicle Type, Type, Level of Automation and Vehicle Class: Global Opportunity Analysis and Industry Forecast, 2021-2030," 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐡𝐲𝐩𝐞𝐫𝐯𝐢𝐬𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟏𝟑𝟏.𝟐𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟎, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟐,𝟎𝟑𝟕.𝟔𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟑𝟏.𝟗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟏 𝐭𝐨 𝟐𝟎𝟑𝟎. North America dominates the market in terms of revenue, followed
Driving Off the Beaten Path : Utility Terrain Vehicle Market to Reach $1.8 Billion by 2032, With a 5.5% CAGR
Driving Off the Beaten Path : Utility Terrain Vehicle Market to Reach $1.8 Billi …
According to the report published by Allied Market Research, 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐮𝐭𝐢𝐥𝐢𝐭𝐲 𝐭𝐞𝐫𝐫𝐚𝐢𝐧 𝐯𝐞𝐡𝐢𝐜𝐥𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟏.𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟓% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟑 𝐭𝐨 𝟐𝟎𝟑𝟐. 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 A utility terrain vehicle (UTVs), also known as a utility task vehicle or side-by-side (SxS), is a specialized off-road vehicle designed for several utility and recreational purposes. UTVs
Speaking Up : Automotive Voice Recognition System Market Set to Reach $14.7 Billion by 2032, Fueled by a 16.1% CAGR
Speaking Up : Automotive Voice Recognition System Market Set to Reach $14.7 Bill …
According to a new report published by Allied Market Research, titled, "Automotive Voice Recognition System Market," 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐯𝐨𝐢𝐜𝐞 𝐫𝐞𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐨𝐧 𝐬𝐲𝐬𝐭𝐞𝐦 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟑.𝟒 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟏𝟒.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟔.𝟏% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟑 𝐭𝐨 𝟐𝟎𝟑𝟐. 𝐅𝐮𝐭𝐮𝐫𝐢𝐬𝐭𝐢𝐜 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 Key trends impacting the automotive voice recognition system market: > 𝐄𝐧𝐡𝐚𝐧𝐜𝐞𝐝 𝐔𝐬𝐞𝐫 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 - The automotive industry prioritizes user satisfaction,
Electric Truck Market to Reach $3.86 Billion by 2030 with a 26.4% CAGR - Industry Report
Electric Truck Market to Reach $3.86 Billion by 2030 with a 26.4% CAGR - Industr …
Allied Market Research (AMR) has recently published a comprehensive report entitled "Electric Truck Market." According to a research report, 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐞𝐥𝐞𝐜𝐭𝐫𝐢𝐜 𝐭𝐫𝐮𝐜𝐤 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟑𝟗𝟐.𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟎, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟑,𝟖𝟔𝟏.𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟐𝟔.𝟒% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟏 𝐭𝐨 𝟐𝟎𝟑𝟎. This research report provides a qualitative and quantitative analysis of recent technological developments, market dynamics, segmental analysis, regional analysis, key investment

All 5 Releases


More Releases for CINV

CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing …
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled “CINV Existing and Pipeline Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the business intelligence firm says that
Chemotherapy-induced Nausea and Vomiting (CINV) Treatment Market Analysis And Fo …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience
Global Cleanliness Analyser System Market 2017-Cinv, Particle Technology Limited …
In this report, the global Cleanliness Analyser System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cleanliness Analyser System in these regions, from 2012 to 2022
Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Research Re …
This report studies Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Plc Helsinn Group Heron Therapeutics Merck & Co Inc Tesaro ... Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of
Chemotherapy Induced Nausea and Vomiting (CINV) - Market Insights, Epidemiology …
Market Research HUB's new report "Chemotherapy Induced Nausea and Vomiting (CINV)- Market Insights, Epidemiology and Market Forecast-2023" Report provides an overview of the disease and global market size of the Chemotherapy Induced Nausea and Vomiting (CINV) in the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the Incident cases of Chemotherapy-Induced Nausea and Vomiting (CINV) from 2013-2023. Request Free